Related Experiment Video

Updated: Nov 11, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.1K

Therapeutic Escape in Gαq-mutant Uveal Melanoma: It's a FAK

J William Harbour1

  • 1Bascom Palmer Eye Institute, Sylvester Comprehensive Cancer Center, and Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, Florida. harbour@miami.edu.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|March 26, 2021
PubMed

Insights

ERK activation causes resistance to FAK inhibition in GNAQ-mutant uveal melanoma. Targeting both PLCB-PKC-ERK and Trio-FAK-Yap pathways may offer a new therapy for metastatic uveal melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • GNAQ-mutant uveal melanoma is an aggressive eye cancer.
  • Resistance to FAK inhibitors is a significant clinical challenge.

Purpose of the Study:

  • To identify mechanisms of resistance to FAK inhibition in GNAQ-mutant uveal melanoma.
  • To explore novel therapeutic strategies for metastatic uveal melanoma.

Main Methods:

  • Conducted a synthetic lethal screen to identify resistance pathways.
  • Investigated the roles of PLCB-PKC-ERK and Trio-FAK-Yap signaling cascades.

Main Results:

  • ERK activation was identified as a key mediator of resistance to FAK inhibition.
  • PLCB-PKC-ERK and Trio-FAK-Yap pathways act as compensatory effectors of mutant Gαq signaling.

Conclusions:

  • Combined inhibition of PLCB-PKC-ERK and Trio-FAK-Yap pathways shows promise as a therapeutic strategy.
  • This approach may overcome FAK inhibitor resistance in GNAQ-mutant uveal melanoma.

More Related Videos

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

703
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.1K